Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 85
Filter
1.
Biomed Pharmacother ; 58(2): 100-10, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14992791

ABSTRACT

Reactive oxygen species (ROS) and oxidative damage to biomolecules have been postulated to be involved in the causation and progression of several chronic diseases, including cancer and cardiovascular diseases, the two major causes of morbidity and mortality in Western world. Consequently dietary antioxidants, which inactivate ROS and provide protection from oxidative damage are being considered as important preventive strategic molecules. Carotenoids have been implicated as important dietary nutrients having antioxidant potential, being involved in the scavenging of two of the ROS, singlet molecular oxygen (1O2) and peroxyl radicals generated in the process of lipid peroxidation. Carotenoids are lipophilic molecules which tend to accumulate in lipophilic compartments like membranes or lipoproteins. Chronic ethanol consumption significantly increases hydrogen peroxide and decreases mitochondrial glutathione (GSH) in cells overexpressing CYP2E1. The depletion of mitochondrial GSH and the rise of hydrogen peroxide are responsible for the ethanol-induced apoptosis. Increased intake of lycopene, a major carotenoid in tomatoes, consumed as the all-trans-isomer attenuates alcohol induced apoptosis in 2E1 cells and reduces risk of prostate, lung and digestive cancers. Cancer-preventive activities of carotenoids have been associated as well as with their antioxidant properties and the induction and stimulation of intercellular communication via gap junctions which play a role in the regulation of cell growth, differentiation and apoptosis. Gap junctional communication between cells which may be a basis for protection against cancer development is independent of the antioxidant property.


Subject(s)
Antioxidants/pharmacology , Cardiovascular Diseases/prevention & control , Carotenoids/pharmacology , Neoplasms/prevention & control , Antioxidants/pharmacokinetics , Antioxidants/therapeutic use , Biological Availability , Cardiovascular Diseases/metabolism , Carotenoids/metabolism , Carotenoids/pharmacokinetics , Carotenoids/therapeutic use , Diet , Gap Junctions/drug effects , Gap Junctions/metabolism , Health Status , Humans , Liver Cirrhosis, Alcoholic/metabolism , Liver Cirrhosis, Alcoholic/prevention & control , Lycopene , Neoplasms/metabolism , Oxidative Stress/drug effects
2.
Biomed Pharmacother ; 57(9): 386-98, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14652164

ABSTRACT

Copper is a trace element, important for the function of many cellular enzymes. Copper ions can adopt distinct redox states oxidized Cu(II) or reduced (I), allowing the metal to play a pivotal role in cell physiology as a catalytic cofactor in the redox chemistry of enzymes, mitochondrial respiration, iron absorption, free radical scavenging and elastin cross-linking. If present in excess, free copper ions can cause damage to cellular components and a delicate balance between the uptake and efflux of copper ions determines the amount of cellular copper. In biological systems, copper homeostasis has been characterized at the molecular level. It is coordinated by several proteins such as glutathione, metallothionein, Cu-transporting P-type ATPases, Menkes and Wilson proteins and by cytoplasmic transport proteins called copper chaperones to ensure that it is delivered to specific subcellular compartments and thereby to copper-requiring proteins.


Subject(s)
Copper/physiology , Trace Elements/physiology , Adenosine Triphosphatases/metabolism , Animals , Biological Transport , Cation Transport Proteins/metabolism , Copper/deficiency , Copper/pharmacokinetics , Copper-Transporting ATPases , Diet , Embryonic and Fetal Development/physiology , Humans , Mammals
3.
Biomed Pharmacother ; 57(8): 321-5, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14568225

ABSTRACT

Coronary heart disease is a major health problem in developed countries. Many studies have shown that elevated serum concentrations of total or low-density-lipoprotein cholesterol (LDL cholesterol) are high risk factors, whereas high concentrations of high-density-lipoprotein cholesterol (HDL cholesterol) or a low LDL to HDL cholesterol ratio may protect against coronary heart disease. Plant sterols and stanols derived from vegetable oils or wood pulp have been shown to lower total and LDL cholesterol levels in humans by inhibiting cholesterol absorption from the intestine. These findings may lead to new therapeutic options to treat hypercholesterolemia. In addition, phytosterols may influence cell growth and apoptosis of tumor cells. However, they can interfere with the absorption of fat soluble vitamins and carotenoids.


Subject(s)
Anticholesteremic Agents/therapeutic use , Cardiovascular Diseases/prevention & control , Hypercholesterolemia/drug therapy , Phytosterols/therapeutic use , Anticholesteremic Agents/chemistry , Cardiovascular Diseases/blood , Cholesterol, HDL/blood , Humans , Hypercholesterolemia/blood , Molecular Structure , Phytosterols/chemistry
4.
Biomed Pharmacother ; 57(7): 301-8, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14499178

ABSTRACT

Anthracyclines are the most commonly used classes of anticancer agents in chemotherapy. Development of resistance to these molecules is one of the major reasons for treatment failure. The overexpression of the membrane transporter P-glycoprotein (P-gp) is among the principal mechanisms involved in this phenomenon. This pump, which is responsible for the multidrug resistance (MDR) phenotype, decreases the toxicity of a wide range of unrelated anticancer drugs by increasing their cellular efflux. Structure-activity relationship experiments have shown that the positively charged amino group of the anthracyclines could be responsible for their transport by P-gp. Here, we used three new anthracyclines that shared the same chromophore but differed by the degree of N-methylation of their sugar moiety. Oxaunomycin (OXN) possessed a non-methylated amino group, while LB-1 was monomethylated and beta-clamycin T (BCT) was dimethylated. In sensitive cells (FLC), reduced cytotoxicity was related to the level of N-methylation; whereas in resistant cells (DOX-RFLC(1) and DOX-RFLC(2)) overexpressing different levels of P-gp, increased N-methylation enhanced anthracycline cytotoxicity. Decreased resistance in DOX-RFLCs was associated with an increased drug accumulation due to a reduced cellular efflux. As expected, the MDR modulator verapamil decreased resistance to these anthracyclines by increasing the cellular accumulation. These results suggest that N-methylation of anthracyclines circumvents resistance by diminishing drug transport by P-gp in MDR-positive cells. These observations could be the consequence of the steric hindrance created by the methyl group(s) which may impair the interaction between the positively charged amino group and the active site of P-gp.


Subject(s)
Anthracyclines/chemistry , Anthracyclines/pharmacokinetics , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacokinetics , Leukemia, Erythroblastic, Acute/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis , Animals , Anthracyclines/pharmacology , Antineoplastic Agents/pharmacology , Biological Transport , Cell Division/drug effects , Cell Survival/drug effects , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Leukemia, Erythroblastic, Acute/pathology , Methylation , Mice , Multidrug Resistance-Associated Proteins/biosynthesis , Structure-Activity Relationship , Tumor Cells, Cultured
5.
Biomed Pharmacother ; 57(3-4): 134-44, 2003.
Article in English | MEDLINE | ID: mdl-12818475

ABSTRACT

Selenium (Se) is an essential trace element for animals and humans that is obtained from dietary sources including cereals, grains and vegetables. The Se content of plants varies considerably according to its concentration in soil. Plants convert Se mainly into Se-methionine (Se-Met) and incorporate it into protein in place of methionine (Met). Selenocystine (Se-Cys), methyl-Se-Cys and gamma-glutamyl-Se-methyl-Cys are not significantly incorporated into plant protein and are at relatively low levels irrespective of soil Se content. Higher animals are unable to synthesize Se-Met and only Se-Cys was detected in rats supplemented with Se as selenite. Renal regulation is the mode by which whole body Se is controlled. Se is concentrated in hair and nail and it occurs almost exclusively in organic compounds. The potentiating effect of Se deficiency on lipid peroxidation is enhanced in some tissues by concurrent deficiency of copper or manganese. In the in vitro system, the chemical form of Se is an important factor in eliciting cellular responses. Although the cytotoxic mechanisms of selenite and other redoxing Se compounds are still unclear, it has been suggested that they derive from their ability to catalyze the oxidation of thiols and to produce superoxide simultaneously. Selenite-induced cytotoxicity and apoptosis in human carcinoma cells can be inhibited with copper (CuSO(4)) as an antioxidant. High doses of selenite result in induction of 8-hydroxydeoxyguanosine (8-OHdG) in mouse skin cell DNA and in primary human keratinocytes. It may cause DNA fragmentation and decreased DNA synthesis, cell growth inhibition, DNA synthesis, blockade of the cell cycle at the S/G(2)-M phase and cell death by necrosis. In contrast, in cells treated with methylselenocyanate or Se methylselenocysteine, the cell cycle progression was blocked at the G(1) phase and cell death was predominantly induced by apoptosis.


Subject(s)
Antioxidants/pharmacology , Selenium Compounds/pharmacology , Selenium/pharmacology , Aging/physiology , Animals , Anticarcinogenic Agents/pharmacology , Antioxidants/pharmacokinetics , Biological Availability , Humans , Proteins/metabolism , Proteins/physiology , Selenium/deficiency , Selenium/pharmacokinetics , Selenium Compounds/pharmacokinetics , Selenoproteins , Tissue Distribution
6.
Biomed Pharmacother ; 56(9): 439-45, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12481980

ABSTRACT

L-Arginine (Arg) is classified as an essential amino acid for birds, carnivores and young mammals and a conditionally essential amino acid for adults. It is converted by arginase to L-ornithine, a precursor of polyamines and urea, which is important in the urea cycle. Arg serves as a precursor for creatine, which plays an essential role in the energy metabolism of muscle, nerve and testis and accounts for Arg catabolism and for the synthesis of agmatine and proteins. Via its ability to increase growth hormone secretion it influences immune function. Depending on nutritional status and developmental stage, normal plasma Arg concentrations in humans and animals range from 95 to 250 micromol/l. Systemic or oral Arg administration has been shown to improve cardiovascular function and reduce myocardial ischemia in coronary artery disease patients. It reduces blood pressure and renal vascular resistance in essential hypertensive patients with normal or insufficient renal function. Although Arg plasma concentrations are not altered in hypercholesterolemic individuals, oral or intravenous Arg administration can reverse endothelial dysfunction in hypercholesterolemic patients and in cigarette smokers. The main importance of Arg is attributed to its role as a precursor for the synthesis of nitric oxide (NO), a free radical molecule that is synthesized in all mammalian cells from L-Arg by NO synthase (NOS). NO appears to be a major form of the endothelium-derived relaxing factor (EDRF). NO and EDRF share similar chemical and pharmacological properties and are derived from the oxidation of a terminal guanidine group of L-Arg. Various mechanisms have been implicated in the defect in vascular relaxation. These include, increased diffusional barrier for NO, L-Arg depletion, altered levels of reactive oxygen, inactivation of NO by superoxide anions (O2-). The independent reactions of O2-, NO and their reaction yielding peroxynitrite are critical in the initiation and maintenance of the atherosclerotic state and contribute to the defect in vasorelaxation. NO also plays a role as a neurotransmitter, mediator of immune response and as signaling molecule. The NO synthesized by iNOS in macrophages contributes to their cytotoxic activity against tumor cells, bacteria and protozoa. Our aim here is to review on some amino acids with high functional priority such as Arg and to define their effective activity in human health and pathologies.


Subject(s)
Arginine/metabolism , Arginine/therapeutic use , Animals , Arginine/administration & dosage , Arginine/physiology , Disease , Health , Humans
7.
Biomed Pharmacother ; 56(9): 446-57, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12481981

ABSTRACT

Glutamine and glutamate with proline, histidine, arginine and ornithine, comprise 25% of the dietary amino acid intake and constitute the "glutamate family" of amino acids, which are disposed of through conversion to glutamate. Although glutamine has been classified as a nonessential amino acid, in major trauma, major surgery, sepsis, bone marrow transplantation, intense chemotherapy and radiotherapy, when its consumption exceeds its synthesis, it becomes a conditionally essential amino acid. In mammals the physiological levels of glutamine is 650 micromol/l and it is one of the most important substrate for ammoniagenesis in the gut and in the kidney due to its important role in the regulation of acid-base homeostasis. In cells, glutamine is a key link between carbon metabolism of carbohydrates and proteins and plays an important role in the growth of fibroblasts, lymphocytes and enterocytes. It improves nitrogen balance and preserves the concentration of glutamine in skeletal muscle. Deamidation of glutamine via glutaminase produces glutamate a precursor of gamma-amino butyric acid, a neurotransmission inhibitor. L-Glutamic acid is a ubiquitous amino acid present in many foods either in free form or in peptides and proteins. Animal protein may contain from 11 to 22% and plants protein as much as 40% glutamate by weight. The sodium salt of glutamic acid is added to several foods to enhance flavor. L-Glutamate is the most abundant free amino acid in brain and it is the major excitatory neurotransmitter of the vertebrate central nervous system. Most free L-glutamic acid in brain is derived from local synthesis from L-glutamine and Kreb's cycle intermediates. It clearly plays an important role in neuronal differentiation, migration and survival in the developing brain via facilitated Ca++ transport. Glutamate also plays a critical role in synaptic maintenance and plasticity. It contributes to learning and memory through use-dependent changes in synaptic efficacy and plays a role in the formation and function of the cytoskeleton. Glutamine via glutamate is converted to alpha-ketoglutarate, an integral component of the citric acid cycle. It is a component of the antioxidant glutathione and of the polyglutamated folic acid. The cyclization of glutamate produces proline, an amino acid important for synthesis of collagen and connective tissue. Our aim here is to review on some amino acids with high functional priority such as glutamine and to define their effective activity in human health and pathologies.


Subject(s)
Glutamic Acid/metabolism , Glutamine/metabolism , Animals , Disease , Glutamic Acid/chemistry , Glutamic Acid/toxicity , Glutamine/chemistry , Health , Humans
8.
Biomed Pharmacother ; 56(5): 215-22, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12199620

ABSTRACT

Linoleic and alpha-linolenic acids, obtained from plant material in the diet are the precursors in tissues of two families with opposing effects which are referred to as "essential fatty acids" (EFA): arachidonic acid (AA) and pentaene (eicosapentaenoic acid: EPA) and hexaene (docosahexaenoic acid: DHA) acids. The role of EFA is crucial, without a source of AA or compounds which can be converted into AA, synthesis of prostaglandins (PGs) by a cyclooxygenase (COX) enzyme would be compromised, and this would seriously affect many normal metabolic processes. COX, also known as prostaglandin endoperoxide synthase (Pghs) or as prostaglandin G/H synthase, is a key membrane bound enzyme responsible for the oxidation of AA to PGs. Two COX isoforms have been identified, COX-1 and COX-2 that form PGH2, a common precursor for the biosynthesis of thromboxane A2 (TxA2), prostacyclin (PGI2) and PGs (PGD2, PGE2, PGF2alpha. COX-1 enzyme is expressed constitutively in most cells and tissues. Its expression remains constant under either physiological or pathological conditions controlling synthesis of those PGs primarily involved in the regulation of homeostatic functions. In contrast, COX-2 is an intermediate response gene that encodes a 71-kDa protein. COX-2 is normally absent from most cells but highly inducible in certain cells in response to inflammatory stimuli resulting in enhanced PG release. PGs formed by COX-2 primarily mediate pain and inflammation but have multiple effects that can favour tumorigenesis. They are more abundant in cancers than in normal tissues from which the cancers arise. COX-2 is a participant in the pathway of colon carcinogenesis, especially when mutation of the APC (Adenomatous Polyposis Coli) tumour suppressor gene is the initiating event. In addition, COX-2 up-regulation and elevated PGE2 levels are involved in breast carcinogenesis. It seems that there is a correlation between COX-2 level of expression and the size of the tumours and their propensity to invade underlying tissue. Inhibition by non-steroidal anti-inflammatory drugs (NSAIDs) of COX enzymes which significantly suppress PGE2 levels, reduced breast cancer incidence and protected against colorectal cancer. Therefore it is suggested that consumption of a diet enriched in n-3 PUFA (specifically EPA and DHA) and inhibition of COX-2 by NSAIDs may confer cardioprotective effects and provide a significant mechanism for the prevention and treatment of human cancers.


Subject(s)
Cardiovascular Diseases/metabolism , Eicosanoids/metabolism , Fatty Acids, Unsaturated/metabolism , Health Status , Neoplasms/metabolism , Cardiovascular Diseases/drug therapy , Cardiovascular Diseases/enzymology , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/pharmacology , Cyclooxygenase Inhibitors/therapeutic use , Eicosanoids/antagonists & inhibitors , Eicosanoids/chemistry , Fatty Acids, Unsaturated/antagonists & inhibitors , Fatty Acids, Unsaturated/chemistry , Humans , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , Membrane Proteins , Neoplasms/drug therapy , Neoplasms/enzymology , Prostaglandin-Endoperoxide Synthases/metabolism
9.
Biomed Pharmacother ; 56(4): 200-7, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12109813

ABSTRACT

Polyphenols are the most abundant antioxidants in our diets. The main classes of polyphenols are phenolic acids (mainly caffeic acid) and flavonoids (the most abundant in the diet are flavanols (catechins plus proanthocyanidins), anthocyanins and their oxidation products), which account for one- and two-thirds, respectively. Polyphenols are reducing agents, and together with other dietary reducing agents, such as vitamin C, vitamin E and carotenoids, referred to as antioxidants, protect the body's tissues against oxidative stress and associated pathologies such as cancers, coronary heart disease and inflammation. The biological properties, bioavailability, antioxidant activity, specific interactions with cell receptors and enzymes, are related to the chemical structure of polyphenols. It is, therefore, essential to know the nature of the main polyphenols ingested, their dietary origin, the amounts consumed in different diets, their bioavailability and the factors controlling their bioavailability.


Subject(s)
Phenols/chemistry , Phenols/therapeutic use , Polymers/chemistry , Polymers/therapeutic use , Antioxidants/chemistry , Antioxidants/pharmacokinetics , Antioxidants/therapeutic use , Biological Availability , Coronary Disease/diet therapy , Coronary Disease/metabolism , Coronary Disease/prevention & control , Enzyme Induction/drug effects , Enzyme Induction/physiology , Flavonoids/chemistry , Flavonoids/pharmacokinetics , Flavonoids/therapeutic use , Humans , Hydroxybenzoates/chemistry , Hydroxybenzoates/pharmacokinetics , Hydroxybenzoates/therapeutic use , Inflammation/diet therapy , Inflammation/metabolism , Inflammation/prevention & control , Neoplasms/diet therapy , Neoplasms/metabolism , Neoplasms/prevention & control , Phenols/pharmacokinetics , Polymers/pharmacokinetics
11.
Biomed Pharmacother ; 56(1): 36-44, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11905507

ABSTRACT

The natural female sex hormone estrogens binds once inside the cell to a protein receptor to form a 'ligand-hormone receptor complex'. The binding activates the hormone receptor, which triggers specific cellular processes. The activated hormone receptor then turns on specific genes, causing cellular changes that lead to responses typical of a ligand-hormone receptor complex. Estrogens (especially estradiol) bring out the feminine characteristics, control reproductive cycles and pregnancy, influence skin, bone, the cardiovascular system and immunity. Natural hormones are more potent than any of the known synthetic environmental estrogens (except drugs such as diethylstilbestrol [DES]). Estrogen production varies according to different factors (gender, age and reproductive cycles). Women produce more estrogen than men and the production is more abundant during fetal development than in the postmenopausal period. Most natural estrogens are short-lived, do not accumulate in tissue and are easily broken down in the liver. In contrast to natural estrogens, estrogenic drugs such as ethynylestradiol diethylstilbestrol (DES), synthetic environmental estrogens such as beta-hexachlorocyclohexane (beta-HCH), polychlorinated biphenyls (PCBs), o, p, p'DDT, 4-nonylphenol (NP) and phytoestrogens such as isoflavones or lignans, are more stable and remain in the body longer than natural estrogens. Because most of these compounds are lipophilic, they tend to accumulate within the fat and tissue of animals and humans. Thus, depending on the natural estrogen levels, environmental estrogens may have different influences (mimicking, blocking or cancelling out estrogen's effects) on estrogen activities.


Subject(s)
Estrogens, Non-Steroidal/chemistry , Estrogens/chemical synthesis , Age Factors , Animals , Cell Division/drug effects , DDT/chemistry , Diethylstilbestrol/chemistry , Environmental Pollutants/adverse effects , Environmental Pollutants/analysis , Estradiol/biosynthesis , Estrogens/biosynthesis , Fabaceae , Hexachlorocyclohexane/chemistry , Humans , Isoflavones/chemistry , Lignans/chemistry , Molecular Structure , Phenols/chemistry , Phytoestrogens , Plant Preparations , Polychlorinated Biphenyls/chemistry , Sex Factors
12.
Biomed Pharmacother ; 55(7): 381-90, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11669501

ABSTRACT

Folate (folic acid, folacin) is an essential vitamin that is found in nature. Folates contain the core chemical structure of pteroylglutamic acid, but vary in their state of reduction, the single carbon moiety they bear and/or the length of the glutamate chain. At least 50% of whole body folate is stored in the liver. The influence of intracellular folate concentration depends largely on dietary intake. The supply of folate depends primarily on the quantity and bioavailability of ingested folate and the rate of loss by urinary and fecal routes and through catabolism.


Subject(s)
Diet , Folic Acid Deficiency/complications , Folic Acid Deficiency/pathology , Folic Acid/therapeutic use , Oxidative Stress/drug effects , Animals , DNA/metabolism , Folic Acid/administration & dosage , Folic Acid/metabolism , Folic Acid Deficiency/genetics , Homocysteine/metabolism , Homocysteine/physiology , Humans , Lipid Peroxidation/physiology , Neoplasms/etiology , Neoplasms/physiopathology , Nutritional Status , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolism , Uracil/metabolism
13.
Biomed Pharmacother ; 55(6): 324-32, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11478585

ABSTRACT

A report from the World Health Organization estimates that 46% of the world's 5- to 14-year-old children are anemic. In addition, 48% of the world's pregnant women are anemic. A majority of these cases of anemia are due to iron deficiency. Our aim here is to review the latest data on iron regulatory mechanisms, iron sources and requirements. Human and animal studies have shown that amino acids and peptides influence iron absorption from the intestinal lumen. Inter-organ transport and uptake of nonheme iron is largely performed by the complex transferring-transferring receptor system. Moreover, the discovery of cytoplasmic iron regulatory proteins (IRPs) has provided a molecular framework from which we understand the coordination of cellular iron homeostasis in mammals. IRPs and the iron responsive elements (IREs) to which they bind allow mammals to make use of the essential properties of iron while reducing its potentially toxic effect. Physiologic iron requirements are three times higher in pregnancy than they are in menstruating women (approximately 1200 mg must be acquired from the body's iron store or from the diet by the end of pregnancy). The administration of iron supplements weekly instead of daily in humans has been proposed and is being actively investigated as a viable means of controlling iron deficiency in populations, including pregnant women.


Subject(s)
Anemia, Iron-Deficiency/prevention & control , Iron/metabolism , Adolescent , Anemia, Iron-Deficiency/blood , Animals , Biological Availability , Diet/standards , Female , Humans , Intestinal Absorption , Iron/blood , Iron/pharmacokinetics , Iron Overload/complications , Lipid Peroxidation , Neoplasms/etiology , Nutritional Requirements , Pregnancy , Receptors, Transferrin/blood , Transferrin/analysis
14.
Biomed Pharmacother ; 53(4): 169-80, 1999 May.
Article in English | MEDLINE | ID: mdl-10392289

ABSTRACT

Exposure to oxidant molecules issued from the environment (pollution, radiation), nutrition, or pathologies can generate reactive oxygen species (ROS for example, H2O2, O2-, OH). These free radicals can alter DNA, proteins and/or membrane phospholipids. Depletion of intracellular antioxidants in acute oxidative stress or in various diseases increases intracellular ROS accumulation. This in turn is responsible for several chronic pathologies including cancer, neurodegenerative or cardiovascular pathologies. Thus, to prevent against cellular damages associated with oxidative stress it is important to balance the ratio of antioxidants to oxidants by supplementation or by cell induction of antioxidants.


Subject(s)
Antioxidants/therapeutic use , Disease , Oxidants/toxicity , Oxidative Stress , Animals , Antioxidants/pharmacology , Humans , Oxidative Stress/drug effects
15.
Toxicol Lett ; 105(2): 163-75, 1999 Mar 29.
Article in English | MEDLINE | ID: mdl-10221278

ABSTRACT

We have conducted a study to determine the carcinogenic potential of ethylene glycol monomethyl ether (EGME), a member of the glycol ether family, as compared to its reactive metabolite 2-methoxy-acetaldehyde (MALD). Since disruption of equilibrium between cell proliferation and cell death is thought to play a key role in multistage carcinogenesis, we investigated, in Syrian hamster embryo (SHE) cells exposed to various doses of EGME and MALD, impairment in apoptosis rate and in ornithine decarboxylase (ODC) metabolism. The activity of this rate-limiting enzyme of polyamine biosynthesis is closely related to cell proliferation and cell transformation. At the end-point, comparative action of the two products on SHE cell morphological transformation frequency was evaluated. One-stage exposure of SHE cells to 2 mM EGME and 200 microM MALD for 5 h did not change basal apoptotic level, whereas 0.16 microM phorbol ester (TPA) decreased it. Using two-stage exposure protocol (1 h xenobiotic followed by 5 h TPA), MALD strongly inhibited apoptosis more than did TPA alone; the parent compound EGME did not have any effect on TPA inhibiting action. Western blotting analysis showed that sequential treatment (MALD/TPA) increased Bcl-2 oncoprotein expression, whereas Bcl-XL and Bax proteins were not changed. The same staged exposure of SHE cells to MALD/TPA strongly induced ODC activity, and the rate was higher than that obtained with TPA alone: this was accompanied by an increase of ODC protein level. This ODC superinduction was not observed with EGME/TPA treatment. In long-term SHE-cell morphological transformation assay, staged exposure to MALD (800 microM or 1 mM for 24 h) followed by TPA applications increased the number of transformed colonies at the seventh day. Such early cooperative events as apoptosis inhibition and ODC superinduction, followed by the increase of SHE-cell transformation frequency, are highly indicative of a carcinogenic potential for the metabolite, MALD.


Subject(s)
Acetaldehyde/analogs & derivatives , Apoptosis/drug effects , Cell Transformation, Neoplastic/drug effects , Embryo, Mammalian/drug effects , Ornithine Decarboxylase/drug effects , Teratogens/toxicity , Acetaldehyde/toxicity , Animals , Carcinogenicity Tests , Cells, Cultured , Cricetinae , DNA Fragmentation/drug effects , Embryo, Mammalian/cytology , Embryo, Mammalian/physiology , Enzyme Induction , Ethylene Glycols/metabolism , Ethylene Glycols/toxicity , Female , Mesocricetus , Ornithine Decarboxylase/biosynthesis , Proto-Oncogene Proteins c-bcl-2/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Tetradecanoylphorbol Acetate/toxicity , Xenobiotics/toxicity , bcl-X Protein
16.
Biomed Pharmacother ; 52(4): 162-5, 1998.
Article in English | MEDLINE | ID: mdl-9755810

ABSTRACT

Audiogenic seizures associated with loss of weight, prostration, piloerection, palpebral ptosis and motor deficiency were induced after sound stimulation of determined frequency and amplitude in magnesium-deficient DBA/2 mice. These symptoms were maintained when standard diet conditions (1700 ppm Mg2+) were restored. In contrast, mice were protected from audiogenic seizure in a dose related manner when Crassostrea gigas extract (JCOE) were added to the diet for 10 consecutive days. Although a rational explanation for this protective effect has not yet been determined, it is assumed that it might be due to a chelating complex formed between Mg2+ and taurine, which enhance the uptake of Mg2+.


Subject(s)
Magnesium Deficiency/physiopathology , Ostreidae , Seizures/physiopathology , Acoustic Stimulation , Animals , Food, Fortified , Magnesium Deficiency/complications , Magnesium Deficiency/diet therapy , Male , Mice , Mice, Inbred DBA , Ostreidae/chemistry , Seizures/etiology , Seizures/prevention & control
17.
Biomed Pharmacother ; 52(6): 282-90, 1998.
Article in English | MEDLINE | ID: mdl-9755828

ABSTRACT

Previously we have detected a stimulatory effect on immunoglobulin (IgG) synthesis when hybridoma cells were treated with doxorubicin. In order to determine whether this is a general property of anthracycline, we have selected three analogs--doxorubicin (DOX), pirarubicin (THP-DOX) and aclarubicin (ACR)--which differ mainly in the methylation state of their amino sugars. Cell cycle analysis by flow cytometry and drug localization by scanning confocal microscopy were also performed. The results show that when cells (UN2 hybridoma B cells), were exposed to subtoxic doses of DOX or THP (with unmethylated amino sugars), a strong increases in IgG secretion, heavy (H) and light (L) chain synthesis and the corresponding mRNA levels were induced. Furthermore these two drugs arrested the cells in the G2/M phase of the cell cycle. In contrast, exposure to ACR (with its methylated amino sugar) at similar subtoxic doses induced a blockade of cells in the G1 phase with no increase of IgG synthesis, at the subtoxic doses used, all three drugs could still be detected in the nucleus as well as in the cytoplasm, as determined by confocal laser microscopy. Thus, the relationship between cell cycle blockade, IgG stimulation and anthracycline structure is suggested by these results.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Cell Cycle/drug effects , Cell Differentiation/drug effects , Aclarubicin/pharmacology , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Cell Division/drug effects , Doxorubicin/analogs & derivatives , Doxorubicin/pharmacology , Hybridomas/cytology , Hybridomas/drug effects , Immunoglobulin G/biosynthesis , Kinetics , Mice , Neoplasms, Experimental , Time Factors
18.
In Vivo ; 12(3): 299-303, 1998.
Article in English | MEDLINE | ID: mdl-9706474

ABSTRACT

Male Sprague Dawley rats received various amounts of extract of Crassostrea gigas by gavage every day for 2 weeks or one month. At these times, groups of animals were sacrificed and samples of major organs analyzed for levels of glutathione (GSH) and glutathione S-transferase (GST) activities. Following the two week protocol, GSH levels were significantly increased in the mucosa of the large intestine; at one month the small intestine and spleen were elevated. GST activity increased in liver under both schedules and at one month, activity was also elevated in kidney and small intestine. Since the Crassostrea gigas extract contains high levels of a variety of important amino acids, it is concluded that biologically available peptides are taken up in target organs and stimulate GSH metabolism. Enhanced levels of GSH and associated enzymes may contribute to a more effective detoxification phenotype, thus providing enhanced chemoprotective capacity.


Subject(s)
Dietary Supplements , Glutathione Transferase/metabolism , Glutathione/metabolism , Ostreidae , Animals , Male , Molecular Structure , Rats , Rats, Sprague-Dawley
19.
In Vivo ; 12(3): 305-9, 1998.
Article in English | MEDLINE | ID: mdl-9706475

ABSTRACT

Since several in vitro and animal studies of an extract from Crassostrea gigas (JCOE) have demonstrated its antioxidant properties and other interesting effects, a preliminary human trial was carried out. Seven healthy male volunteers aged 23-37 received orally 3 x 2 capsules of JCOE per day for 8 days. On days 0, 1, 4, 8 and 15 (7 days after completion of the schedule) blood samples were drawn and the antioxidant potential of serum was tested. A statistically significant increase in the buffering effects of serum against hemoglobin (Hb) and lactate dehydrogenase (LDH) release from red blood cells treated with the free radical generator azobis amidino propane (AAPH) was found following JCOE treatment. At 8 days, the oxidative effects were reduced by > 90% of the pretreatment values. In these same individuals, serum levels of reduced glutathione were increased by an average of 1.5-fold over the time course of treatment. It is concluded that in normal human volunteers, JCOE capsules provide an orally available formula for enhancing the antioxidant capacity of blood serum. While the extract is known to contain some direct acting antioxidant components, at least a portion of the protective effect is facilitated by enhancement of GSH biosynthesis.


Subject(s)
Antioxidants/pharmacology , Ostreidae , Adult , Animals , Glutathione Transferase/blood , Hemoglobins/metabolism , Humans , L-Lactate Dehydrogenase/blood , Male
20.
Int J Cancer ; 75(5): 744-9, 1998 Mar 02.
Article in English | MEDLINE | ID: mdl-9495243

ABSTRACT

As part of environmental toxicology, it is important to assess both the carcinogenic potential of xenobiotics and their mode of action on target cells. Since dysregulation of ornithine decarboxylase (ODC), a rate-limiting enzyme of polyamine biosynthesis, is considered as an early and essential component in the process of multistage carcinogenesis, we have studied the mode of ODC induction in Syrian-hamster-embryo(SHE) cells stage-exposed to carcinogens and to non-carcinogens. One-stage (5 hr) treatment of SHE cells with 50 microM clofibrate (CLF), a non-genotoxic carcinogen, or with 0.4 microM benzo(a)pyrene (BaP), a genotoxic carcinogen, slightly decreased basal ODC activity. Using the 2-stage exposure, 1 hr to carcinogen, then replacement by TPA for 5 hr, the ODC activity was higher than that obtained with TPA alone. This ODC superinduction was not observed when SHE cells were similarly pre-treated with non-carcinogenic compounds. Several environmental chemicals, pesticides, solvents, oxidizers and drugs were investigated with this SHE cell model. With one-stage exposure, some xenobiotics decreased basal ODC activity, while for others ODC changes were not noticeable. With 2-stage exposure (chemical followed by TPA), all carcinogens amplified the TPA-inducing effect, resulting in ODC superinduction. Comparative studies of the action of carcinogens and of non-carcinogens, using 2-stage exposure protocols, clearly show a close relationship between ODC induction rate and morphological transformation frequency.


Subject(s)
Carcinogens/administration & dosage , Cell Transformation, Neoplastic/drug effects , Ornithine Decarboxylase/biosynthesis , Animals , Benzo(a)pyrene/administration & dosage , Cells, Cultured , Clofibrate/administration & dosage , Cricetinae , Drug Administration Schedule , Enzyme Induction/drug effects , Mesocricetus/embryology , Tetradecanoylphorbol Acetate/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL